Headwinds in GoodRx’s (GDRX) Drug Prescription Business Draw Cautious View from Jefferies

3 weeks ago 11

Miko Ilas

Fri, February 6, 2026 astatine 10:16 AM CST 1 min read

GoodRx Holdings Inc. (NASDAQ:GDRX) is 1 of the champion stocks nether $3 to put in, though 1 steadfast had precocious go neutral connected the stock. On January 22, analysts astatine Jefferies lowered their standing connected GoodRx Holdings Inc. (NASDAQ:GDRX) to Hold from Buy and chopped the terms people to $2.75 from $5.25. According to Jefferies, the Rite Aid bankruptcy and the consequent wide closures of 800 pharmacy locations from June to July 2025 person adversely affected GoodRx’s cause medicine concern to the tune of a 14% year-over-year diminution successful monthly progressive consumers and a 9% driblet successful medicine revenues.

GoodRx (GDRX) Received Downgrade, Price Target Cut from Jefferies

adriaticfoto/Shutterstock.com

Jefferies expects GoodRx Holdings Inc. (NASDAQ:GDRX)’s medicine revenues to stay level year-over-year arsenic it continues to look challenges successful its medicine discount segment, which represents astir 69% of the company’s expected revenue. The analysts besides task that wide gross and EBITDA maturation volition stay muted, making GoodRx’s valuation aggregate stagnant astatine slightest successful the abbreviated run.

GoodRx Holdings Inc. (NASDAQ:GDRX) is simply a integer healthcare level that offers consumers escaped entree to transparent and little prices for branded and generic medications.

While we admit the imaginable of GDRX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 11 Best Stocks Under $3 to Buy Right Now and 10 Most Undervalued Stocks to Buy and Hold for 5 Years

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.